CYMEVENE FOR INJECTION 500 mg Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

cymevene for injection 500 mg

dksh singapore pte. ltd. - ganciclovir sodium eqv ganciclovir - injection, powder, for solution - 500 mg - ganciclovir sodium eqv ganciclovir 500 mg

CYMEVENE 500 MG Ισραήλ - Αγγλικά - Ministry of Health

cymevene 500 mg

tzamal bio-pharma ltd - ganciclovir as sodium - powder for solution for infusion - ganciclovir as sodium 500 mg - ganciclovir - cymevene iv is indicated for the treatment of cmv retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (aids). cymevene iv is also indicated for the prevention of cmv disease in transplant recipients at risk for cmv disease.

Prevymis Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

prevymis

merck sharp & dohme (new zealand) limited - letermovir 240mg - film coated tablet - 240 mg - active: letermovir 240mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry yellow 39k120004 povidone as povidone 25 purified water - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Prevymis Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

prevymis

merck sharp & dohme (new zealand) limited - letermovir 480mg - film coated tablet - 480 mg - active: letermovir 480mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry pink 39k140009 povidone as povidone 25 purified water - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

Ganciclovir SXP Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

ganciclovir sxp

southern cross pharma nz ltd - ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - powder for injection - 500 mg - active: ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease. note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.